Pfizer's danuglipron is an agonist that upregulate
Post# of 148282
(Total Views: 778)
Posted On: 07/28/2022 1:18:36 PM
Pfizer's danuglipron is an agonist that upregulates GLP-1. Once again a drug that targets only one small piece of the puzzle. Leronlimab upregulates GLP-1 along with the myriad of other effects. Interestingly another GLP-1 agonist called Rybelsus has been approved by the FDA to treat type 2 diabetes. Rybelsus has a black box warning for a host of very bad side effects.
(14)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼